Calzada receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Polynovo Ltd (PNV)
Track today's live Polynovo (PNV) share price, performance and key data on this page with our current Sydney:PNV stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Polynovo share price on the Sydney exchange. Use the dropdown to switch exchange for the PNV share price, head to our technical summary section, which provides analysis on Polynovo share price buy/sell indicators using real-time data (or discuss the Polynovo (PNV) stock price today with other investors in the Polynovo ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:PNV share price (ISIN: AU000000PNV0) to enhance your trading decisions with our free investment tools and resources.
What Is the Polynovo Ltd Share Price Today?
The Polynovo share price today is 0.875.
What Is the Stock Symbol for Polynovo Ltd
The stock symbol (or 'ticker') for Polynovo Ltd is "PNV."
What Stock Exchange Does Polynovo Ltd Trade On?
Polynovo Ltd is listed and trades on the Sydney stock exchange.
Is Polynovo Ltd a Good Stock to Buy?
Determining whether Polynovo (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:PNV share price (ISIN: AU000000PNV0) to enhance your trading decisions with our free investment tools and resources.
What Is the Polynovo Ltd Share Price Today?
The Polynovo share price today is 0.875.
What Is the Stock Symbol for Polynovo Ltd
The stock symbol (or 'ticker') for Polynovo Ltd is "PNV."
What Stock Exchange Does Polynovo Ltd Trade On?
Polynovo Ltd is listed and trades on the Sydney stock exchange.
Is Polynovo Ltd a Good Stock to Buy?
Determining whether Polynovo (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
0.875
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.865
0.890
52 wk Range
0.810
1.665
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8650.890
52 wk Range
0.8101.665
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PNV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
1.460
Upside
+66.90%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Calzada receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Calzada receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
5 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1.460
(+66.90% Upside)
Earnings
Latest Release
22/07/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 83M
Compare PNV to Peers and Sector
Metrics to compare | PNV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPNVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 61.2x | −1.6x | −0.4x | |
PEG Ratio | 0.91 | 0.07 | 0.00 | |
Price/Book | 7.3x | 2.4x | 2.6x | |
Price / LTM Sales | 4.3x | 1.8x | 3.1x | |
Upside (Analyst Target) | 42.9% | 94.8% | 48.8% | |
Fair Value Upside | Unlock | 22.3% | 5.7% | Unlock |
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Polynovo (Sydney: PNV) Share Price Today?
The Polynovo stock price today is 0.875 AUD.
What Stock Exchange Does Polynovo (PNV) Trade On?
Polynovo is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Polynovo?
The stock symbol (also called a 'ticker') for Polynovo is "PNV."
What Is the Current Polynovo Market Capitalisation?
As of today, Polynovo (Sydney: PNV) market cap is 604.490M AUD.
What Is Polynovo's (PNV) Earnings Per Share (TTM)?
The Polynovo EPS is currently 0.014 (Trailing Twelve Months).
When Is the Next Polynovo Earnings Date?
Polynovo's next earnings report will be released on 21/08/2026.
Is PNV a Buy or Sell From a Technical Analyst Perspective?
Based on today's Polynovo moving averages and other technical indicators, the daily buy/sell signal for PNV stock is Strong Sell.
How Many Times Has Polynovo Stock Split?
Polynovo has split 0 times. (See the PNV stock split history page for full effective split date and price information.)
How Many Employees Does Polynovo Have?
Polynovo has 301 employees, based on their latest Companies House report.
What is the current trading status of Polynovo (Sydney: PNV)?
As of 09/08/2026, Polynovo (PNV) is trading at a share price of 0.875 AUD, with a previous close of 0.875 AUD. The stock has fluctuated within a day range of 0.865 AUD to 0.890 AUD, while its 52-week range spans from 0.810 AUD to 1.665 AUD.
What Is Polynovo (PNV) Price Target According to Analysts?
The average 12-month price target for Polynovo is 1.460 AUD, with a high estimate of 2.65 AUD and a low estimate of 0.95 AUD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +66.90% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.